ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it has received FDA approval for its ...

U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring(R) Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as ...

TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...

The UK has just seen the first case of treatment for benign prostatic hyperplasia (BPH) with Rezūm™ Water Vapour Therapy using the newly launched Rezūm™ EVO Console at Basingstoke and North Hampshire ...

Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...

Profound Medical ( ($TSE:PRN) ) has issued an announcement. Profound Medical announced the launch of its TULSA-AI Volume Reduction module, ...

TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...

GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).

Benign prostatic hyperplasia (BPH) is the leading cause of lower urinary tract symptoms among the aging male population. Epidemiological, pathophysiological and clinical studies indicate that many of ...